Maricel Apuli insider trades
Open-market stock purchases and sales by Maricel Apuli, Chief Accounting Officer at BridgeBio Pharma, Inc, from SEC Form 4 filings since Mar 19, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 16, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $312K |
| Apr 30, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $143K |
| Mar 18, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Feb 26, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $132K |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $37.9K |
| Feb 16, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $327K |
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $151K |
| Dec 8, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $149K |
| Nov 16, 2025 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $317K |
Companies traded
- BBIO BridgeBio Pharma, Inc: 6 sales, last May 16, 2026